Penn Startup Vivodyne Raises $40 Million to Advance Human Tissue Testing Platform
Vivodyne was co-founded by Dan Huh, PhD, Professor of Bioengineering in Penn Engineering and CEO Andrei Georgescu.,
Philadelphia Ranks #13 Globally, Climbing Up 12 Spots, in 2025 Global Startup Ecosystem Report
The 2025 Global Startup Ecosystem Report has been released.
Three Penn I-Corps Teams Participated in State-wide Pitch Event
Three Penn I-Corps teams participated in the SmartTech Tournament on April 10 and 11, 2025 as part of the Invent Penn State Venture & IP Conference.
2025 President’s Innovation Prize Winner Announced
The team is developing a privacy-centric AI system to support eldercare by reducing staff burnout and addressing gaps in caregiving.
Veradermics Closes Series B Financing and Initiates Phase 2/3 Trial for Hair Loss
Veradermics is a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions.
Vivodyne Weighs in on FDA Proposed Initiative
The FDA recently revealed a new initiative aimed at eliminating the need to test antibody therapeutics in animal models and replacing them with AI modelling or lab-grown human organoids.
Philadelphia Launches SBIR/STTR Matching Grant Program
Philadelphia has launched a new matching grant program to support local life sciences companies.
BioSpace Interviews Penn Spinout Leaders About Life Sciences Growth in Philadelphia
In an article by BioSpace, Philadelphia is showcased as a major life sciences hub.
Vetigenics secures $6 million seed financing
The funding will be used to further advance clinical-stage programs toward pivotal trials, accelerate preclinical candidates, and scale the company's operations and manufacturing.
Stentix Wins the 2025 Y-Prize
The team behind Stentix plans to continue developing the technology for several adjustable stent applications.